Details for New Drug Application (NDA): 209040
✉ Email this page to a colleague
The generic ingredient in TAFLUPROST is tafluprost. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tafluprost profile page.
Summary for 209040
Tradename: | TAFLUPROST |
Applicant: | Sandoz |
Ingredient: | tafluprost |
Patents: | 0 |
Pharmacology for NDA: 209040
Mechanism of Action | Prostaglandin Receptor Agonists |
Physiological Effect | Increased Prostaglandin Activity |
Suppliers and Packaging for NDA: 209040
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TAFLUPROST | tafluprost | SOLUTION/DROPS;OPHTHALMIC | 209040 | ANDA | Sandoz Inc | 0781-6184 | 0781-6184-87 | 6 POUCH in 1 CARTON (0781-6184-87) / 5 CONTAINER in 1 POUCH (0781-6184-14) / .3 mL in 1 CONTAINER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.0015% | ||||
Approval Date: | Jan 28, 2022 | TE: | AT | RLD: | No |
Complete Access Available with Subscription